Novel orthotopic patient-derived xenograft model using human pancreatic cancer tissue fragments to recapitulate distant metastasis and cancer-related hypercoagulability
Medical Molecular Morphology · 2025
DOI: 10.1007/s00795-025-00425-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Molecular Morphology, 2025. Verfasst von Takuma Miura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-Ku, Kobe, 654-0142, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Thrombophilia, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Kobe University.
Abstract (Originalsprache)
Pancreatic cancer is a malignant tumor that metastasizes to distant organs, such as the liver and lungs from an early stage. Few animal models can reproduce early metastasis. In addition, no model has been reported that reproduces cancer-related hypercoagulability, which is characteristic of pancreatic ductal adenocarcinoma and other adenocarcinomas. We hypothesized that the reason why the commonly used orthotopic cell xenograft model cannot reproduce the disease is inadequate construction of the cancer microenvironment. We developed an orthotopic tissue fragment xenograft model in which tumor tissue was transplanted into the pancreas of mice while preserving the microenvironment. Briefly, we injected single cancer cells subcutaneously to form a tumor, which was then cut with a scalpel into tumor fragments. A fragment was then sutured and fixed to the surface of the pancreatic tail. In this study, we evaluated the superiority of this model over a conventional orthotopic cell xenograft model. As a result, the novel orthotopic tissue xenograft model reproduced early distant metastasis to the liver and lung, nerve invasion, and cancer-related hypercoagulability of human pancreatic cancer, and showed greater similarity to clinical cases than the control orthotopic cell xenograft model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biophysics, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-Ku, Kobe, 654-0142, Japan.
- Department of Nursing, Kobe University Graduate School of Health Sciences, Kobe, Japan.
- Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
- Department of Internal Medicine, National Hospital Organization Kobe Medical Center, Kobe, Japan.
- Department of Biophysics, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka, Suma-Ku, Kobe, 654-0142, Japan. horiy@people.kobe-u.ac.jp.
Förderung
- Japan Society for the Promotion of Science
- Kobe University
Zitieren
APA
Miura, T., Watanabe, A., Miyake, M., Suga, S., Miyoshi, M., Miyashita, K., Komatsu, S., Nishimura, N., Shimizu, K., & Hori, Y. (2025). Novel orthotopic patient-derived xenograft model using human pancreatic cancer tissue fragments to recapitulate distant metastasis and cancer-related hypercoagulability. Medical Molecular Morphology. https://doi.org/10.1007/s00795-025-00425-3
Vancouver
Miura T, Watanabe A, Miyake M, Suga S, Miyoshi M, Miyashita K, et al. Novel orthotopic patient-derived xenograft model using human pancreatic cancer tissue fragments to recapitulate distant metastasis and cancer-related hypercoagulability. Medical Molecular Morphology. 2025. doi:10.1007/s00795-025-00425-3
BibTeX
@article{Miura2025,
author = {Miura, Takuma and Watanabe, Arisa and Miyake, Mutsumi and Suga, Sayaka and Miyoshi, Makoto and Miyashita, Kumiko and Komatsu, Shohei and Nishimura, Noriyuki and Shimizu, Kazuya and Hori, Yuichi},
title = {Novel orthotopic patient-derived xenograft model using human pancreatic cancer tissue fragments to recapitulate distant metastasis and cancer-related hypercoagulability},
journal = {Medical Molecular Morphology},
year = {2025},
doi = {10.1007/s00795-025-00425-3}
}
EUVIMED